Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Legal Cultures and Literary Trials in the Age of Goethe. The Vehmic Court Motif in Interdisciplinary and Comparative Perspective (VehmeLit)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Social Sciences and Humanities
Countries involved: United Kingdom
Call: Individual Fellowships (H2020-MSCA-IF-2016, 2016)
Start date: 2018-01-01
End date: 2019-12-31
Duration (months): 24.0
Total project cost (EUR): 183454.8
EU funding (EUR): 183454.8
Participants: 1
Project status: CLOSED

The project aims at a first systematic and in-depth investigation of the motif of the Vehmic Court – a medieval secret tribunal – in German literature of the late 18th and early 19th centuries. Despite the remarkable popularity of the subject, little research has yet been conducted to define the epistemological framework of its development. By dismissing the Vehme as a “trivial” trope, scholars have not grasped its broader relevance for the culture of the Saddle Period around 1800, an age of transitions and paradigm shifts in society and politics, but also in literature, historiography and the legal system. Through a close-reading analysis and interpretation of a corpus of around twenty plays and novels on the topic, most of which will be examined for the first time, Dr Vecchiato will clarify the reasons for the flourishing of Vehmic Court fictions in the Age of Goethe. By situating the texts within the cultural and historical horizon in which they were produced, he will shed new light on the interactions between popular and canonical literature, Law and Literature as well as Literature and History in that period. Furthermore, he will explore the cross-cultural dimension of the topic, by studying its reception in British literature. The project is a natural outgrowth of the researcher’s interest in the literature of the Age of Goethe; at the same time it grants him the possibility to acquire new competences and multidisciplinary knowledge, which will be crucial for the development of a broader research on the literary representation of trial scenes in German literature. Besides offering outstanding intellectual exchange and the possibility to establish international collaborations, a MSC-IF at King’s College London will help Dr Vecchiato further enhance his scholarly profile and track record of publications. Through teaching, dissemination and outreach activities, he will be able to reach full professional maturity and to generate impacts in and beyond academia.

Keywords: german literature,age of goethe,vehmic court,law and literature,literature and history
The second coordination and support action for the JPI Healthy Diet for a Healthy Life (CSA JPI HDHL 2.0)

Framework: Horizon 2020 — Societal Challenges
Programme: Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the bioeconomy
Action type: Coordination and support actions
Countries involved: Germany,Italy,Germany,Spain,New Zealand,Belgium,France,France,Czechia,Netherlands
Call: Coordination action in support of the implementation by participating States of a Joint Programming Initiative on ‘A Healthy Diet for a Healthy Life’ (H2020-ISIB-2015-1, 2015)
Start date: 2016-02-01
End date: 2021-06-30
Duration (months): 65.0
Total project cost (EUR): 2426126.25
EU funding (EUR): 1998800.75
Participants: 11
Project status: CLOSED

The main objectives of the 2nd Coordination and Support Action (CSA) of the Joint Programming Initiative Healthy Diet for a Healthy Life (JPI HDHL) are to support the further implementation of JPI HDHL and to create a sustainable collaboration of Member States (MS), the European Commission (EC) and related international organisations. Support facilitated by the 2nd CSA will ensure sufficient progress on alignment and also on the ethos of joint programming in the area of nutrition and health becoming embedded within Member States’ research and innovation policies and programmes. The 2nd CSA will focus specifically on these issues and will take into account foresight and evaluation activities as important aspects for the future of research in the scientific and policy areas covered within the JPI HDHL. Objectives of the 2nd CSA: 1. Alignment of national research programs on health and nutrition 2. Mature collaboration between the MS and focus on a sustainable support structure for the JPI. 3. Increase collaboration with important stakeholders. Industry, science and policy will be invited to take ownership of areas of the JPI which are under their responsibility. 4. Communication activities of the JPI will increase to make the JPI an even more important player in the area of Nutrition & Health. 5. Show the impact of joint programming on Nutrition & Health within the MS. The evaluation of the JPI will go beyond pure process indicators and will focus on effect and impact evaluation. 6. The collaboration within the JPI will move beyond Europe. In the first phase Canada and New Zealand have become partners, but the next five years will be used to broaden the scope of the JPI to new interested countries with a specific focus on Asia and the America’s.

Keywords: member states,nutrition,diet and health,strategic research agenda,sustainability,implementation
Foundations and Tools for Client-Side Web Security (Browsec)

Framework: Horizon 2020 — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Consolidator grants
Action type: ERC actions
Panel: Computer science and informatics
Panel description: Informatics and information systems, computer science, scientific computing, intelligent systems
Countries involved: Austria
Call: ERC Consolidator Grant (ERC-2017-COG, 2017)
Start date: 2018-06-01
End date: 2024-11-30
Duration (months): 78.0
Total project cost (EUR): 1990000.0
EU funding (EUR): 1785000.0
Participants: 2
Project status: SIGNED

The constantly increasing number of attacks on web applications shows how their rapid development has not been accompanied by adequate security foundations and demonstrates the lack of solid security enforcement tools. Indeed, web applications expose a gigantic attack surface, which hinders a rigorous understanding and enforcement of security properties. Hence, despite the worthwhile efforts to design secure web applications, users for a while will be confronted with vulnerable, or maliciously crafted, code. Unfortunately, end users have no way at present to reliably protect themselves from malicious applications. BROWSEC will develop a holistic approach to client-side web security, laying its theoretical foundations and developing innovative security enforcement technologies. In particular, BROWSEC will deliver the first client-side tool to secure web applications that is practical, in that it is implemented as an extension and can thus be easily deployed at large, and also provably sound, i.e., backed up by machine-checked proofs that the tool provides end users with the required security guarantees. At the core of the proposal lies a novel monitoring technique, which treats the browser as a blackbox and intercepts its inputs and outputs in order to prevent dangerous information flows. With this lightweight monitoring approach, we aim at enforcing strong security properties without requiring any expensive and, given the dynamic nature of web applications, statically infeasible program analysis. BROWSEC is thus a multidisciplinary research effort, promising practical impact and delivering breakthrough advancements in various disciplines, such as web security, JavaScript semantics, software engineering, and program verification.

Keywords: web security,formal methods,program verification
Competing Regional Integrations in Southeast Asia (CRISEA)

Framework: Horizon 2020 — Societal Challenges
Programme: Europe in a changing world - inclusive, innovative and reflective societies
Theme: Inclusive societies
Action type: Research and Innovation actions
Countries involved: Germany,Italy,Indonesia,Norway,Poland,Malaysia,Thailand,Myanmar,France,Philippines,United Kingdom,Portugal,Viet Nam
Call: The Asia-Pacific as a strategic region for Europe (H2020-SC6-ENG-GLOBALLY-2017, 2017)
Start date: 2017-11-01
End date: 2021-02-28
Duration (months): 40.0
Total project cost (EUR): 2500000.0
EU funding (EUR): 2500000.0
Participants: 13
Project status: CLOSED

The project Competing Regional Integrations in Southeast Asia (CRISEA) brings together Southeast Asian (SEA) and European researchers with 3 objectives. 1. Research. Our previous research shows that SEA is open to multiple forces that drive regional integration through competition for resources and legitimacy. In the current crisis of legitimacy for globalisation, SEA's competing regional integrations present challenges for its people and for ASEAN's framework-building project. We analyse these in sectorally-themed work packages on 'arenas of competition': the environment, the economy, the State, the identity of SEA's people, and the Region. Using an interdisciplinary micro-macro method of analysis, we ask in each case how ASEAN-led regional integration is – and is seen by SEA's people as – part of the problem or part of the solution. CRISEA engages with the work programme's concern with "what ‘region’ means to the peoples of these countries within and beyond the ASEAN context". Closely aligned with the 2015 Joint Communication on EU-ASEAN relations, it enhances the EU's understanding of "the Asia-Pacific as a strategic region for Europe". 2. Policy relevance. CRISEA's research programme was developed for its relevance to EU policy on ASEAN and its member states. Its dissemination strategy innovates by creating mechanisms for dialogue with a targeted audience of policy makers, stakeholders and the public in Brussels and SEA, using briefing sessions, workshops, press coverage, film, public lectures and policy briefs. 3. Networking and capacity building for the European Research Area. Leveraging existing networks of EU-SEA cooperation – the unique EFEO network of 10 field centres in SEA, the IDEAS and SEATIDE projects, EUROSEAS, ASEF – we reinforce the ERA through coordinated academic exchange, joint research and results delivery. Our consortium engages western European and ASEAN scholars with emerging expertise in southern and eastern Europe.

Keywords: asean,capitalism,china,competition,connectivity,crisis,development,environment,gender,globalisation,identity,integration,legitimacy,migration,regionalism,security,state,southeast asia
The simplest and most efficient platform to unify medical records and manage health care professionals. (ePersonam)

Framework: Horizon 2020 — Industrial Leadership
Programme: Information and Communication Technologies
Action type: SME instrument
Countries involved: Italy
Call: Open Disruptive Innovation Scheme (H2020-SMEINST-1-2016-2017, 2017)
Start date: 2017-12-01
End date: 2018-03-31
Duration (months): 4.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

The ultimate objective of the ePersonam project is to launch to market a complete solution to unify the fragmented Hospital Information Systems, under the umbrella of a software platform to control own medical records and all vital parameters with the possibility of connecting with the attending physician and clinical centres. Current alternatives do not solve the challenge as they are either specific for each Hospital or they use a client-server structure (not complete cloud-based system). Our solution is not another health management tool. We offer a solution which simplifies the number of tasks and provide a visible value to each stakeholder, providing only relevant information and only when needed. The benefits for clients, end users, and society include: (1) Constant monitoring and therefore improvement of the state of health on aging diseases, chronic diseases, and severe disabilities. (2) The improvement through prevention and control, active aging and living with chronic diseases. This will decrease hospitalization and thereby (3) reduce the economic impact on healthcare companies and the community, while maintaining a high level of monitoring and assistance service. Furthermore, it allows the end user to (4) always have the complete and comprehensive situation of his own medical. We are a private owned SME founded in 2012 by professionals who have worked together since 2005, both in health and software companies, gaining considerable experience in these sectors. Besides our qualified personnel, our strength resides on our established cooperation with hospitals and clinics, as our software is already being used in over 500 facilities and by 20,000 active users. We have estimated that after 5 years from launch, we will we will have engaged more than 100.000 people (sales €5.1M), hired 15 new technical employees, and managed 0.6% of the global market. We will earn almost €4.9M profit and generate a R.O.I of 2.68 by commercializing this technology.

Keywords: health intelligence,integrated hospital information systems,efficient medical management,smart medical services,personalized management,global integrative systems
The High Throughput Satellite Enabler Instrument: HTSInstrument (HTSEmpower)

Framework: Horizon 2020 — Industrial Leadership
Programme: Space
Action type: SME instrument
Countries involved: Spain
Call: Engaging SMEs in space research and development (H2020-SMEINST-2-2016-2017, 2017)
Start date: 2017-06-01
End date: 2019-03-31
Duration (months): 22.0
Total project cost (EUR): 1158750.0
EU funding (EUR): 811125.0
Participants: 1
Project status: CLOSED

The satellite industry has developed dramatically over recent years, both in terms of capability and competitiveness. The satellite “facelift” mainly culminates around High Throughput Satellite (HTS). The technology will allow that more people can access services via, and it that satellite is a viable alternative to other types of connection. This in turn has led to a veritable explosion in service provision, giving our industry the chance to shine, but not without a few hurdles. The emergence of HTS makes those terminals all the more efficient and reliable. As such, HTS has already having an impact on Very Small Aperture Terminal (VSAT) deployments. That is set to increase further, with Northern Sky Research estimating that the broadband VSAT market will reach $10billion by 2021. HTS is somehow a victim of its own success. Rapid growth means that operators are deploying in more and more large networks to cope with the extra demand, which often need to be deployed in a short time frame. Installers need to travel long distances and spend a considerable amount of time carrying out the installation. Reducing installation time can therefore save valuable time and cost. Moreover, it is quite often a bad alignment of the antenna causing a multitude of problems, including satellite interference. The technology to make installations easier, faster and to reduce errors both at installation and throughout operation is available and this proposal targets the deployment of an instrument that Integrasys is developing during last years addressing to (1) Drastically simplify the installing and commissioning VSAT-based satellite services, ensuring the required technical quality and reducing the cost of VSAT deployment, and (2) Easy-to-use technology which opens, for the first time, the door to accurate self-customer installation by simplifying the installation process through intuitive tools and allowing the VSAT installer to self-check critical parameters in real time

Keywords: satellite communication,interference mitigation,high troughput satellite,network,infrastructure,vsat,mobile professional communications,digital divide
Innovative System for Electrical Energy Efficiency in industrial plants (EFICONSUMPTION)

Framework: Horizon 2020 — Societal Challenges
Programme: Secure, clean and efficient energy
Action type: SME instrument
Countries involved: Spain
Call: Stimulating the innovation potential of SMEs for a low carbon energy system (H2020-SMEINST-1-2014, 2014)
Start date: 2014-10-01
End date: 2015-02-28
Duration (months): 5.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

The general objective of EFICONSUMPTION will be focused on the development and further commercialization of an innovative system able to reduce the electricity consumption in industries in a percentage up to 40%, related in terms of unitary energy cost, by means of an optimal measurement, monitoring, smart modeling, remote control and horizontal scalable management of industrial plant production and service processes. The new solution will be a combination of a specific device able to measure the main electricity parameters at any place, and an expert system, which will receive the real time data and will be able to establish efficient consumption patterns to effectively reduce the electricity consumption. This reduction will also contribute to reduce carbon footprint and emissions. EFICONSUMPTION has the following specific objectives to be accomplished in this first stage: - To develop a business and exploitation plan adjusted to the technical and commercial features of the project, including the assessment of the cost-effectiveness and exploitation potential of the envisaged solution. - To tackle the main bottlenecks and barriers for the full commercialization of the innovative technologies, mainly related to legislative and regulatory aspects in each country. - To widely disseminate project outcomes to stakeholders and end-users, strengthening synergies with other initiatives and platforms to reach the maximum impact. - To analyse the market and business strategies in the sector in order to find the best combination of external agents and international entities to develop cooperation strategies for market exploitation and further products commercialization.

Keywords: electricity consumption,efficiency,measurement,metering,energy,emissions,industries,modeling,real time,exploitation plan,business,commercialization,feasibility study,market analysis
Use of MIN-102 for the treatment of children with cerebral ALD (MIN4ALD)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: SME instrument
Countries involved: Spain
Call: SME instrument (H2020-SMEInst-2018-2020-2, 2018)
Start date: 2018-10-01
End date: 2022-06-30
Duration (months): 45.0
Total project cost (EUR): 5216567.51
EU funding (EUR): 3106250.0
Participants: 1
Project status: CLOSED

The objective of the MIN4ALD project is the development of a new pharmacological therapy to treat paediatric patients with cerebral ALD (cALD) - the most rapidly progressive and devastating phenotype of X-ALD (X-linked adrenoleukodystrophy). cALD is a rare, fatal genetic disorder that affects nerve cells in the brain. Symptoms of cALD usually occur in a boy’s early childhood, and are characterized by rapidly progressive loss of visual, auditory, motor and cognitive function, with death usually occurring after 2 to 4 years from disease onset. Currently, there is no pharmacological treatment available on the market. The only existing alternative for cALD patients is hematopoietic stem cell transplantation, yet the procedure itself is very aggressive and results are not always optimal. Minoryx has developed a candidate drug that has demonstrated in several studies an excellent potential to treat patients with X-ALD. MIN4ALD Phase 2 demonstration is key to bring this unique treatment to the market. The results obtained in the Feasibility Analysis carried out indicated that MIN4ALD could be a huge business opportunity within the orphan diseases market. The Global orphan diseases market is a niche market valued at US$ 121.6 billion in 2015. It is expected to grow to US$ 576.9 billion by 2022, with an average CAGR of 24.9% during the period 2015-2022. This is an impressive growth compared to the Global pharma market, which projects a 6.3% CAGR through 2022. Minoryx has raised an important funding amount for R&D development from leading investors and has the support of reference Key Opinion Leaders. Minoryx received Orphan Drug Designation from both EU and FDA and holds a patent application covering the use of MIN-102 for X-ALD and other diseases affecting the central nervous system. MIN4ALD will suppose a crucial stimulus for Minoryx to expand internationally and improve time-to-market, leading to the consolidation of the company in the pharmaceutical market.

Keywords: rare diseases,cald
Intelligent plug-and-play digital tool for real-time surveillance of COVID-19 patients and smart decision-making in Intensive Care Units (ENVISION)

Framework: Horizon 2020 — Societal Challenges
Programme: Health, demographic change and wellbeing
Action type: Innovation actions
Countries involved: Germany,Italy,Italy,Germany,Germany,Germany,Germany,Spain,Belgium,Finland,Hungary,Romania,Slovenia,Slovenia,Lithuania,Romania,Switzerland,Netherlands,United Kingdom,Portugal
Call: Medical technologies, Digital tools and Artificial Intelligence (AI) analytics to improve surveillance and care at high Technology Readiness Levels (TRL) (H2020-SC1-PHE-CORONAVIRUS-2020-2-CNECT, 2020)
Start date: 2020-12-01
End date: 2023-07-31
Duration (months): 32.0
Total project cost (EUR): 5660486.25
EU funding (EUR): 4874111.25
Participants: 24
Project status: SIGNED

Within only six months, over 7.4 million people have been diagnosed with SARS-CoV-2. In the most severely hit countries, more than 10% of infected patients have received treatment in Intensive Care Units (ICUs). Insufficient data and limited knowledge on the disease as well as the lack of tools to support the intensivist in making accurate, timely and informed decisions has led to high mortality rates. Continuous surveillance, the collection and intelligent analysis of data from many sources, including ventilators and electrical impedance tomography, would allow intensivists to decide on the best suitable treatment to accelerate the recovery of the often comorbid COVID-19 patients, while reducing the burden on clinical staff and healthcare costs. This information would also increase our understanding of the yet unknown course of disease, supporting other stakeholders in the quest for new therapies. In ENVISION, our multidsciplinary public-private consortium will advance an innovative digital tool, Sandman.MD, a real-time and plug-and-play monitoring app, to an intelligent decision-support system for monitoring, prediction and treatment of COVID-19 patients in ICUs – the Sandman.ICU – reaching Technology Readiness Level 9 and ready for CE marking by the end of the project. The app has been developed by our SME partner app@work and successfully introduced by several hospitals in Germany for use during the perioperative period. Sandman.ICU will be integrated into an AI-driven data analytics suite with predictive modelling tools and enhanced with a smart alert functionality. The digital tool will be validated and demonstrated in 14 hospitals across Europe. Our Health Technology Assessment expert partner will demonstrate the economic and societal value of Sandman.ICU, while an experienced SME will manage the innovation process in view of an immediate market uptake. The rollout will be supported by the European Society of Anaesthesiology and Intensive Care.

Keywords: covid 19,critical care,intensive care unit,data analytics,real time monitoring,predictive modelling,artificial intelligence,digitalisation,monitoring,acute respiratory distress syndrome